Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2021-12-09 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed with the Korean financial authorities. It details the issuance of new shares, the purpose of capital raising, the list of third-party allottees, and the pricing methodology. This falls under the category of announcements regarding new share issues and capital structure changes.
2021-12-09 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed by BioProtech. It details the issuance of new shares, the purpose of the capital increase, the list of third-party allottees, and the specific terms of the shares (including conversion and dividend rights). This is a formal regulatory filing concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-12-09 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market for significant corporate events, specifically capital raising through debt instruments. Since it details the terms, purpose, and issuance of convertible bonds, it falls under the 'Capital/Financing Update' category.
2021-12-09 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by BioProtech. It contains detailed terms of the bond issuance, including interest rates, conversion prices, maturity dates, and the purpose of the funds. This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2021-12-09 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a third-party paid-in capital increase (유상증자결정). It details the issuance of new shares, the purpose of the capital raise, the allocation to specific entities (Mijin Company and Sanremo Corporation), and the terms of the preferred shares. This is a formal regulatory filing concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-12-09 Korean
기타시장안내(상장유지 결정 및 매매거래 재개 안내 )
Delisting Announcement Classification · 1% confidence The document is a short regulatory announcement from the Korea Exchange regarding the decision to maintain the listing of BioProtech and the resumption of trading. It does not contain full financial statements or audit reports, but rather serves as a formal notice of a regulatory decision. As it does not fit into specific categories like M&A or dividend announcements, it falls under the general regulatory filing category.
2021-12-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.